[Increased intraocular pressure in asthma patients].
Schröder
Henning
H
Institut für Pharmakologie und Toxikologie für Naturwissenschaftler, Martin-Luther-Universität, Halle. henning.schroeder@pharmazie.uni-halle.de
D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000627:therapeutic use; D018927:Anti-Asthmatic Agents / Q000009:adverse effects*; D001249:Asthma / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology*; D015784:Betaxolol / Q000009:adverse effects / Q000627:therapeutic use; D005901:Glaucoma / Q000209:etiology; D005938:Glucocorticoids / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D009798:Ocular Hypertension / Q000209:etiology* / Q000503:physiopathology*
D000318:Adrenergic beta-Agonists; D018927:Anti-Asthmatic Agents; D005938:Glucocorticoids; D015784:Betaxolol